June 10, 2020 / 5:41 PM / 23 days ago

BRIEF-PharmAbcine Execute An Agreement With Thermo Fisher For Development, Manufacturing Of Its Next-Generation Immune Checkpoint Blockade

June 10 (Reuters) - PharmAbcine Inc:

* PHARMABCINE EXECUTE AN AGREEMENT WITH THERMO FISHER FOR THE DEVELOPMENT AND MANUFACTURING OF ITS NEXT-GENERATION IMMUNE CHECKPOINT BLOCKADE, PMC-309 FOR PHASE I Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below